Klow
KLOW is a four-peptide research blend combining GHK-Cu, TB-500, BPC-157, and KPV in a single 80 mg lyophilized vial. Research on the individual components has examined extracellular-matrix and collagen activity, cell migration, angiogenic signaling, inflammatory cytokine pathways, and tissue-repair models. The blend is supplied for researchers investigating multiple signaling pathways together and comparing blended versus single-compound systems.
$160.00
- FormatLyophilized powder blend, 80mg vial
- Storage-20°C for long-term stability
KLOW is a multi-peptide blend combining several research compounds in a single 80 mg freeze-dried vial. Research on its individual components has explored…
50 in stock
About Klow
KLOW is a four-peptide research blend combining GHK-Cu, TB-500, BPC-157, and KPV in a single 80 mg lyophilized vial. Research on the individual components has examined extracellular-matrix and collagen activity, cell migration, angiogenic signaling, inflammatory cytokine pathways, and tissue-related models. The blend is supplied for researchers investigating multiple signaling pathways together and comparing blended versus single-compound systems.
Full Specification
| Molecular Formula | C₂₁₂H₃₅₀N₅₆O₇₈S |
| Purity | ≥99% (HPLC verified) |
| Appearance | White to off-white lyophilized powder |
| Storage | -20°C for long-term stability |
| Format | Lyophilized powder blend, 80mg vial |
The Klow Molecule
An illustrative representation generated from the compound's molecular formula, alongside its logged molecular data. This figure is schematic — not a measured conformation.
How Klow Works
The pathways Klow acts on — and what each one does. The animation traces its signal outward from the compound to every target it engages.
Signalling pathways studied in preclinical models · illustrative
Growth-Factor & Angiogenic Signalling
BPC-157 + TB-500BPC-157 is studied in preclinical skin, tendon, muscle, and bone models through growth-factor upregulation and angiogenic signaling, while TB-500 is studied for cell migration and fibrotic endpoints.
Extracellular Matrix & Collagen
GHK-CuGHK-Cu is a copper-binding tripeptide studied in fibroblast and extracellular-matrix models involving collagen and elastin synthesis, endothelial activity, and fibroblast migration.
Inflammation Modulation
KPVKPV is the C-terminal tripeptide of α-MSH and has been studied in relation to NF-κB and MAP-kinase signaling, with lower inflammatory cytokine output reported in research models.
What Klow Is Researched For
Tendon, Muscle & Connective Tissue
BPC-157 and structurally related peptide research includes preclinical tendon, muscle, bone, and connective-tissue models.
Cell Migration & Angiogenesis
BPC-157, TB-500, and GHK-Cu are studied in in-vitro and ex-vivo systems to investigate endothelial activity, cell migration, and matrix-related signaling.
Skin, Collagen & Wound Models
GHK-Cu is studied in collagen and elastin synthesis models, while the blend is investigated in dermal and wound-related research models.
Peptide Class Pharmacology
The four peptide components are studied for their signaling mechanisms and preclinical activity across tissue and cellular models.
Study-Reported Magnitudes
Representative figures from published research; results vary by protocol.
Common Questions About Klow
KLOW is a four-peptide research blend containing GHK-Cu, TB-500, BPC-157, and KPV combined into an 80 mg lyophilized vial.
GHK-Cu is studied in collagen and extracellular-matrix research, TB-500 in cell migration and fibrotic models, BPC-157 in growth-factor and angiogenic research, and KPV in inflammatory signaling models.
The blend combines peptides studied across complementary pathways, allowing researchers to investigate multiple signaling systems together and compare blended versus individual compounds.
The supplied source does not provide evidence that KLOW is FDA approved. KLOW is supplied as a research-use-only peptide blend.
Research on the four components includes connective-tissue models, cell migration, angiogenesis, collagen and dermal models, inflammatory signaling, and peptide-class pharmacology.
The supplied specification recommends storage at -20°C for long-term stability.